Contribution of allelic imbalance to colorectal cancer
0301 basic medicine
GENES
DNA Copy Number Variations
Genotype
Science
Denmark
Transcription Factors/genetics
Loss of Heterozygosity
colorectal cancer
Allelic Imbalance
Article
Proto-Oncogene Proteins p21(ras)/genetics
Proto-Oncogene Proteins p21(ras)
03 medical and health sciences
Humans
Point Mutation
ddc:576.5
Genetic Predisposition to Disease
RNA, Small Interfering
paksusuolisyöpä
RNA, Small Interfering/genetics
Chromosome Aberrations
Whole Genome Sequencing
HUMAN-COLON
info:eu-repo/classification/ddc/576.5
Gene Expression Profiling
Q
Genomics
Colorectal Neoplasms/genetics
3. Good health
GENOME
ENHANCERS
Biomedicine
Phenotype
syöpägeenit
CELLS
Tumor Suppressor Protein p53/genetics
mutaatiot
CRISPR-Cas Systems
Tumor Suppressor Protein p53
Colorectal Neoplasms
Chromosomes, Human, Pair 8
Microsatellite Repeats
Transcription Factors
DOI:
10.1038/s41467-018-06132-1
Publication Date:
2018-09-04T09:47:50Z
AUTHORS (40)
ABSTRACT
Point mutations in cancer have been extensively studied but chromosomal gains and losses more challenging to interpret due their unspecific nature. Here we examine high-resolution allelic imbalance (AI) landscape 1699 colorectal cancers, 256 of which whole-genome sequenced (WGSed). The imbalances pinpoint 38 genes as plausible AI targets based on previous knowledge. Unbiased CRISPR-Cas9 knockout activation screens identified total 79 within peaks regulating cell growth. Genetic functional data implicate loss TP53 a sufficient driver AI. WGS highlights an influence copy number aberrations the rate detected somatic point mutations. Importantly, reveal several associations between target genes, suggesting role for network lineage-determining transcription factors tumorigenesis. Overall, results unravel contribution provide explanation why so few are commonly affected by cancers.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (39)
CITATIONS (31)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....